Detalhe da pesquisa
1.
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial.
HIV Clin Trials
; 14(6): 274-83, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-24334180
2.
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19.
EClinicalMedicine
; 45: 101310, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35237748
3.
Nitazoxanide and probiotics for the treatment of recurrent Clostridium difficile infection in a peritoneal dialysis patient.
South Med J
; 102(7): 746-7, 2009 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-19488013
4.
Short communication: Nitazoxanide inhibits HIV viral replication in monocyte-derived macrophages.
AIDS Res Hum Retroviruses
; 31(2): 237-41, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25303025
5.
Nitazoxanide for the empiric treatment of pediatric infectious diarrhea.
Trans R Soc Trop Med Hyg
; 106(3): 167-73, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22301075